Financial Year |
March 31 2023 |
Monetary Funds |
66,172,427,267.00 |
Held-for-trading Financial Assets |
2,918,086,597.00 |
Notes Receivable |
418,605,166.00 |
Accounts Receivable |
40,675,836,031.00 |
Advances to Suppliers |
7,766,780,046.00 |
Other Receivables |
3,866,934,551.00 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
3,194,171,427.00 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
3,749,176,090.00 |
Other Current Assets |
29,949,349,413.00 |
Total Current Assets |
159,031,780,943.00 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
615,755,089.00 |
Long-term Equity Investment |
51,922,073,796.00 |
Investment Properties |
-- |
Fixed Assetes |
295,203,280,279.00 |
Under-construction Projects |
48,217,892,341.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
29,077,304,535.00 |
R&D expenses |
3,241,870,982.00 |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
3,701,239,251.00 |
Deferred Income Tax Assets |
526,364,984.00 |
Other Non-Current Assets |
6,725,145,548.00 |
Sub-Total of Non-Current Assets |
492,705,662,335.00 |
Total Assets |
651,737,443,278.00 |
Short-Term Loans |
569,968,305.00 |
Trading Financial liabilities |
-- |
Notes Payable |
11,510,183,097.00 |
Accounts Payable |
143,288,999,689.00 |
Accounts Received In Advance |
310,027,033.00 |
Employee Compensation Payable |
14,063,095,269.00 |
Taxes Payable |
4,247,453,573.00 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
16,007,081,202.00 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
12,824,067,270.00 |
Other Current Liabilities |
6,970,822,484.00 |
Sub-Total of Current Liabilities |
252,559,532,633.00 |
Long-term Loans |
1,778,987,926.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
13,349,882.00 |
Special Payable |
-- |
Estimatied Liabilities |
254,148,491.00 |
Deferred Income Tax Liabilities |
695,159,482.00 |
Other Non-Current Liabilities |
659,109,268.00 |
Sub-Total of Non-Current Liabilities |
46,442,113,039.00 |
Total Liabilities |
299,001,645,672.00 |
Paid-In Capital(Or Share Stock) |
31,804,436,237.00 |
Capital Surplus |
81,895,546,315.00 |
Surplus Reserve |
2,552,931,421.00 |
LESS:Treasury Stock |
4,297,801,978.00 |
Undistributed Profits |
47,644,639,070.00 |
Minority Stockholder's Interest |
195,942,453,166.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
156,793,344,440.00 |
Owner's Equity(Stockholder's Equity) |
352,735,797,606.00 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
651,737,443,278.00 |